Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Immunoproliferative Disorders
>>
Nippon Kayaku
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Zinapar
(darinaparsin) / Solasia, Meiji Seika, Nippon Kayaku
buparlisib
(AN2025) / Novartis, Adlai Nortye, Nippon Kayaku
